Committee Meeting Updates

Vineet Laboratories' Rights Issue Committee meeting has been adjourned to December 17. The committee requires more time to finalize key aspects of the proposed Rights Issue, including the Issue Price, Entitlement Ratio, and the issue's opening and closing dates.

These crucial decisions are contingent on receiving necessary preliminary approval.

This adjournment impacts the timeline for the company's capital raise, underscoring the careful process involved in setting terms for new share issuance.